Welcome to the future of personalized medicine.

In 2013, the Food & Drug Administration (FDA) released a report entitled “Paving the Way for Personalized Medicine,” in which they detail the approval of drugs for use in cancer patients with gene-specific tumors, a new therapeutic for a rare form of cystic fibrosis, as well as a 3D-printed bioresorbable tracheal splint used to recreate an airway in a critically-ill infant. This New Era of Medical Product Development quickly evolved…

Read More